drugset / Trial / NCT06015074

Ciprofol vs Propofol for Reducing Hypoxia Incidence in ERCP

NCT06015074

Unknown 136 enrolled RenJi Hospital
RandomizedParallel-groupDouble-blindOther

Summary

Intravenous anesthesia has been widely used in endoscopic retrograde cholangiopancreatography (ERCP). In the past decade, many practices have been carried out under the propofol-based monitored anesthesia care without endotracheal intubation in patients undergoing ERCP. Ciprofol is a newly developed intravenous anesthetic with a potency 4-5 times than that of propofol. Ciprofol seems a promising anesthetic agent for intravenous anesthesia but the evidence supported its application in ERCP is still limited.

Timeline

Start
2024-06-15
Primary completion
2024-12-31
Completion
2025-02-28

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule 0.8 mg/kg Intravenous
Comparator Propofol Small molecule 5 mg/kg Intravenous